Our studies in endothelial cell biology aim to identify novel therapeutic targets in the battle against cardiovascular disease and type 2 diabetes. Read More.
We are investigating the initiating mechanisms by which hypercholesterolemia changes the microenvironment in the artery wall to drive atherogenesis. Read More.
We are interrogating how events in endothelial cells convert risk factors into clinical thrombotic events, including those underlying myocardial infarction and stroke. Read More.
Springboarding from our discovery that endothelial processes underlie how obesity causes insulin resistance, we are attacking type 2 diabetes pathogenesis from an entirely new angle. Read More.
